Full video transcriptClick to expand
Auto-generated transcript of @lowkey_fish_'s video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00New PEP can boost critical thinking skills, enhance reflexism, perception, elevate your
- 0:04overall mood, and much more.
- 0:06It tends to give stimulant-like effects, but it's different than traditional stimulants
- 0:09because you don't exactly get the feeling of being wired.
- 0:12It's given out as a prescription of Russia, although it can be obtained through over-the-counter
- 0:15purchase in the United States.
- 0:17It does not appear in blood tests, and in most areas of the world, it is legal and unregulated.
- 0:21New PEP helps you develop a memory to something, retain the memory, and then recall that memory
- 0:25at a later time.
- 0:26You are so smart.
- 0:27This makes it highly effective at being a study drug.
- 0:30It can also be a good conversation drug because it increases verbal fluidity, allowing your
- 0:34dialogue to flow smoothly.
- 0:35Clinical evidence suggests that new PEP boosts communication and neuron signaling by boosting
- 0:39alpha and beta brain wave activity.
- 0:41This will protect neurons and make it easier to enter the flow state, improve creativity,
- 0:45and makes you more prone to executing more resourceful and innovative decisions.
- 0:48By entering the flow state, it allows you to defocus on non-important things and hold
- 0:52your attention into exactly the task you wish to complete.
Noopept as a nootropic: what the science actually supports
Quick answer
Noopept (omberacetam) is a synthetic dipeptide developed in Russia with a mechanism involving AMPA receptor potentiation and cholinergic signaling. Human clinical trials are limited to cognitively impaired populations, primarily elderly patients with mild cognitive impairment or post-stroke recovery, and results are modest. No peer-reviewed randomized controlled trials in healthy adult populations support the cognitive enhancement claims made in this video.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Noopept as a nootropic: what the science actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Noopept as a nootropic: what the science actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Noopept as a nootropic: what the science actually supports" from Lowkey Fish 🐠. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Noopept (omberacetam) is a synthetic dipeptide developed in Russia with a mechanism involving AMPA receptor potentiation and cholinergic signaling.
The reason this review is not generic is the source wording and the canonical claim label "peptides using noopept as a nootropic noopept nootropics cognitiveenh." In this clip, the useful excerpt is: "New PEP can boost critical thinking skills, enhance reflexism, perception, elevate your overall mood, and much more." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Emerging pharmacotherapies for obesity: A systematic review (2025), Glucagon-like receptor agonists and next-generation incretin-based medications (2026), and Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Noopept (omberacetam) is a synthetic dipeptide developed in Russia with a mechanism involving AMPA receptor potentiation and cholinergic signaling.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Noopept (omberacetam) is a synthetic dipeptide developed in Russia with a mechanism involving AMPA receptor potentiation and cholinergic signaling. Human clinical trials are limited to cognitively impaired populations, primarily elderly patients with mild cognitive impairment or post-stroke recovery, and results are modest. No peer-reviewed randomized controlled trials in healthy adult populations support the cognitive enhancement claims made in this video.
- All clinical trials showing Noopept benefits were conducted in cognitively impaired populations, not healthy adults, meaning the 'study drug' framing is not supported by existing evidence.
- Noopept modulates NGF and BDNF expression in rodent studies (Ostrovskaya et al., 2007), but animal model results have not been replicated in large-scale human trials.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- All clinical trials showing Noopept benefits were conducted in cognitively impaired populations, not healthy adults, meaning the 'study drug' framing is not supported by existing evidence.
- Noopept modulates NGF and BDNF expression in rodent studies (Ostrovskaya et al., 2007), but animal model results have not been replicated in large-scale human trials.
- The creator is correct that Noopept is not scheduled under the US Controlled Substances Act and does not appear on standard SAMHSA drug panels, but absence from a drug test does not establish safety.
- EEG alpha and beta band changes were observed in one small Russian study (Kondratenko et al., 2011), but EEG shifts do not automatically produce measurable improvements in memory or executive function.
- Noopept has shown anxiolytic-like properties in animal models, which raises unstudied interaction risks with psychiatric medications including SSRIs, SNRIs, and benzodiazepines.
- The 'verbal fluidity' and 'flow state' claims have zero peer-reviewed support and should be treated as anecdote, not pharmacology.
- Long-term safety data for Noopept in healthy human populations does not exist. Any use should be discussed with a clinician familiar with your full medication and health history.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @lowkey_fish_ actually say?
The creator made a stack of claims about Noopept, which they called "New PEP" throughout the video. The short version: Noopept boosts critical thinking, memory encoding and recall, verbal fluidity, and alpha and beta brain wave activity. They also said it produces stimulant-like effects without the "wired" feeling, functions as a "study drug" and a "conversation drug," and helps users enter a "flow state." They also noted it does not appear in blood tests and is legal and unregulated in most of the world.
One factual claim worth flagging immediately: the creator said Noopept "is given out as a prescription in Russia." That part is true. Noopept (omberacetam) is a registered pharmaceutical in Russia, developed by the Zakusov Institute of Pharmacology. The rest of the claims get more complicated.
Does the science back this up?
Partially, but mostly in animal models and small Russian clinical trials, which is a significant caveat. The human evidence for Noopept as a cognitive enhancer in healthy adults is thin to nonexistent.
Noopept does appear to modulate NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor) expression in rodent studies. Ostrovskaya et al. (2007, Bulletin of Experimental Biology and Medicine) showed neuroprotective effects in rat models of Alzheimer's-type pathology. Gudasheva et al. (1997, European Journal of Medicinal Chemistry) described its mechanism as enhancing acetylcholine neurotransmission, which is plausible for memory-adjacent effects.
The claim about boosting "alpha and beta brain wave activity" does have a small basis. A 2011 study by Kondratenko et al. published in Russian journal Eksperimental'naya i Klinicheskaya Farmakologiya found EEG changes in alpha and beta bands after Noopept administration. But this was a small, non-peer-reviewed-by-Western-standards study, and EEG band changes do not automatically translate to better cognition in a meaningful way.
The "flow state" and "conversation drug" framing? There is no clinical evidence for either. That is speculation dressed up as pharmacology.
What did they get wrong (or right)?
They got the legal and regulatory framing mostly right. Noopept is not scheduled in the United States, not FDA-approved, and technically available as a research compound. It does not show up on standard SAMHSA drug panels. Those are accurate statements.
They got the memory mechanism directionally right. Noopept is thought to work on AMPA receptor potentiation and cholinergic signaling, which relates to encoding, consolidation, and retrieval. Framing it as helping you "develop a memory, retain the memory, and then recall that memory" is oversimplified but not factually wrong in spirit.
What they got wrong is the confidence level. Describing Noopept as "highly effective" as a study drug is not supported by human clinical trial data. Every robust study on Noopept has been conducted in cognitively impaired populations, mostly elderly patients with mild cognitive impairment. Guekht et al. (2017, Zhurnal Nevrologii i Psikhiatrii) found modest benefits in patients recovering from ischemic stroke. That does not mean it sharpens the cognition of a healthy 22-year-old cramming for finals.
The "verbal fluidity" claim is essentially unsubstantiated in peer-reviewed literature. Anecdotal. The creator should have said so.
What should you actually know?
Noopept sits in a gray zone that makes it genuinely hard to evaluate. It is not a supplement with decades of safety data. It is not a prescription drug in the US with an FDA-reviewed risk profile. It is a research compound with a real pharmacological mechanism, limited human trials, and zero long-term safety data in healthy populations.
The absence from drug tests the creator mentions is accurate, but worth contextualizing differently than they did. It does not mean Noopept is safe. It means it has not been included in standard panels because it is not a controlled substance. Those are different things.
If you are considering any nootropic compound, the conversation should happen with a clinician who understands your full medical history, not based on a 60-second TikTok. Some compounds in this category interact with medications, particularly antidepressants and anxiolytics. Noopept specifically has shown some anxiolytic-like properties in animal models, which raises questions about interactions that nobody has studied in humans at scale.
The "smart drug" framing is also worth questioning on principle. Cognitive enhancement in healthy adults remains one of the least-supported ideas in all of neuropharmacology. That does not mean nothing works. It means the bar for evidence should be higher than it is in most nootropic content online.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Lowkey Fish 🐠 · TikTok creator
6.8K views on this video
Using Noopept as a Nootropic! #Noopept #Nootropics #CognitiveEnhancement #BrainHealth #SmartDrugs #MemorySupport #Focus #MentalClarity #NootropicStack #BrainBoost #CognitiveFunction #NootropicCommunity #MemoryEnhancement #MindEnhancement #NootropicReview #Neuroenhancement #CognitiveSupport #MentalPerformance #BrainSupplements #NootropicBenefits #NoopeptReview #CognitiveAbilities #Neurotransmitters #MentalFocus #NootropicsForStudents #BrainOptimization #MemoryRetention #Neuroplasticity #MentalAgi
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about all clinical trials showing noopept benefits were conducted in cognitively?
All clinical trials showing Noopept benefits were conducted in cognitively impaired populations, not healthy adults, meaning the 'study drug' framing is not supported by existing evidence.
What does the video say about noopept modulates ngf?
Noopept modulates NGF and BDNF expression in rodent studies (Ostrovskaya et al., 2007), but animal model results have not been replicated in large-scale human trials.
What does the video say about the creator?
The creator is correct that Noopept is not scheduled under the US Controlled Substances Act and does not appear on standard SAMHSA drug panels, but absence from a drug test does not establish safety.
What does the video say about eeg alpha?
EEG alpha and beta band changes were observed in one small Russian study (Kondratenko et al., 2011), but EEG shifts do not automatically produce measurable improvements in memory or executive function.
What does the video say about noopept has shown anxiolytic-like properties in animal models,?
Noopept has shown anxiolytic-like properties in animal models, which raises unstudied interaction risks with psychiatric medications including SSRIs, SNRIs, and benzodiazepines.
What does the video say about the 'verbal fluidity'?
The 'verbal fluidity' and 'flow state' claims have zero peer-reviewed support and should be treated as anecdote, not pharmacology.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Lowkey Fish 🐠, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.